New York University School of Medicine

Oncology & Cancer

Small molecules inhibit growth of human tumor cells

Researchers from the Cancer Institute at NYU Langone Medical Center have identified three novel small molecules that interrupt a crucial cellular communication pathway that regulates many aspects of development and cancer. ...

Sleep disorders

New quality measures approved for childhood sleep apnea

A work group of physicians from leading academic medical centers across the country, including NYU Langone Medical Center, has developed new quality measures for the detection and treatment of childhood obstructive sleep ...

Oncology & Cancer

Researchers identify key role of microRNAs in melanoma metastasis

Researchers at the NYU Cancer Institute, an NCI-designated cancer center at NYU Langone Medical Center, identified for the first time the key role specific microRNAs (miRNAs) play in melanoma metastasis to simultaneously ...

Cardiology

New hidden heart attack culprit identified in women

Researchers at the Cardiac & Vascular Institute at NYU Langone Medical Center have identified a hidden culprit in the battle against women's heart disease. Plaque disruption, a rupture or ulceration of cholesterol plaque ...

Oncology & Cancer

Immune system infighting explains pancreatic cancer's aggression

Internal conflict between cell types explains why the immune system struggles to recognize and attack pancreatic cancer. Curbing this infighting has the potential to make treatment more effective, according to a study led ...

Oncology & Cancer

Researchers find new way to target blood stem cell cancers

A protein-sugar molecule, CD99, occurs more frequently than normal on stem cells responsible for blood cancers, including acute myeloid leukemia (AML) and the related myelodysplastic syndromes (MDS).

page 7 from 30